SecSonar.com

Cibus, Inc. (CBUS)

Cibus, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Cibus, Inc. (CBUS) is a Biotechnology company based in US with a market capitalization of $66.6M. Revenue declined 14.6% year-over-year and free cash flow was negative at -$51.2M. This page tracks CBUS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 157 employees · IPO Jul 20, 2017

Valuation

Valuation & price

$1.31 · as of May 17, 2026 · -67.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.05

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.97$2.60$1.22Jul 25Dec 25Jul 26Jul 7, 25$1.47Jul 9, 25$1.58Jul 11, 25$1.56Jul 15, 25$1.57Jul 17, 25$1.73Jul 21, 25$1.65Jul 23, 25$1.75Jul 25, 25$1.61Jul 29, 25$1.55Jul 31, 25$1.48Aug 4, 25$1.58Aug 6, 25$1.56Aug 11, 25$1.40Aug 13, 25$1.42Aug 15, 25$1.41Aug 19, 25$1.37Aug 21, 25$1.25Aug 25, 25$1.32Aug 27, 25$1.32Aug 29, 25$1.34Sep 3, 25$1.28Sep 5, 25$1.28Sep 9, 25$1.41Sep 11, 25$1.40Sep 16, 25$1.38Sep 18, 25$1.35Sep 22, 25$1.36Sep 24, 25$1.33Sep 26, 25$1.30Sep 30, 25$1.29Oct 2, 25$1.49Oct 6, 25$1.49Oct 8, 25$1.47Oct 10, 25$1.40Oct 14, 25$1.47Oct 16, 25$1.71Oct 21, 25$1.55Oct 23, 25$1.58Oct 27, 25$1.65Oct 29, 25$1.59Oct 31, 25$1.60Nov 4, 25$1.37Nov 6, 25$1.25Nov 10, 25$1.33Nov 12, 25$1.35Nov 14, 25$1.22Nov 18, 25$1.30Nov 20, 25$1.26Nov 25, 25$1.33Nov 28, 25$1.36Dec 2, 25$1.34Dec 4, 25$1.61Dec 8, 25$1.59Dec 10, 25$1.66Dec 12, 25$1.61Dec 16, 25$1.56Dec 18, 25$1.54Dec 22, 25$1.76Dec 24, 25$1.75Dec 29, 25$1.63Jan 2, 26$1.88Jan 6, 26$2.34Jan 8, 26$2.05Jan 12, 26$1.90Jan 14, 26$1.95Jan 16, 26$1.90Jan 21, 26$1.51Jan 23, 26$1.63Jan 27, 26$1.80Jan 29, 26$1.92Feb 2, 26$2.08Feb 4, 26$2.30Feb 9, 26$2.05Feb 11, 26$2.09Feb 13, 26$2.30Feb 18, 26$3.12Feb 20, 26$2.99Feb 24, 26$3.69Feb 26, 26$3.52Mar 2, 26$3.71Mar 4, 26$3.33Mar 6, 26$3.16Mar 10, 26$3.97Mar 12, 26$3.91Mar 17, 26$3.68Mar 19, 26$2.66Mar 23, 26$2.77Mar 25, 26$2.87Mar 27, 26$1.88Mar 31, 26$1.98Apr 2, 26$1.98Apr 7, 26$1.59Apr 9, 26$1.26Apr 13, 26$1.45Apr 15, 26$1.44Apr 17, 26$1.59Apr 22, 26$1.49Apr 24, 26$1.50Apr 28, 26$1.42Apr 30, 26$1.40May 4, 26$1.49May 6, 26$1.59May 8, 26$1.44May 12, 26$1.43May 14, 26$1.41May 18, 26$1.28May 20, 26$1.42May 22, 26$1.38May 28, 26$1.45Jun 1, 26$1.47Jun 3, 26$1.39Jun 5, 26$1.29Jun 9, 26$1.23Jun 11, 26$1.25Jun 15, 26$1.27Jun 17, 26$1.29Jun 22, 26$1.30Jun 24, 26$1.37Jun 26, 26$1.36Jul 2, 26$1.39
$1.1652-week range$4.05
Loading valuation history…

Fundamentals

Key fundamentals

$66.6M

Market cap

-14.6%

Revenue growth (YoY)

-62.8%

Gross margin

-$51.2M

Free cash flow (USD)

$258M

Net debt

1870.4%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$399.0KFY 2017$508.0KFY 2018$236.0KFY 2019$7.3MFY 2020$23.9MFY 2021$26.0MFY 2022$157.0KFY 2023$1.8MFY 2024$4.3MFY 2025$3.6M
$399K$3.6M

Free cash flow by year

2016 → 2025

FY 2016$-19.7MFY 2017$-13.6MFY 2018$-22.1MFY 2019$-34.9MFY 2020$-45.5MFY 2021$-19.3MFY 2022$-20.9MFY 2023$-50.5MFY 2024$-58.9MFY 2025$-51.2M
-$19.7M-$51.2M

Gross margin by year

2021 → 2025

FY 2021-9.9%FY 2022-877.1%FY 202378.3%FY 2024100.0%FY 2025-62.8%
-9.9%-62.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.33)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCEO AppointmentJun 9, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 5, 2026Filing
  • FinancingSecurities RegistrationMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventDirector AppointmentApr 10, 2026Filing

Questions

Frequently asked questions

What is Cibus, Inc.'s market cap?

Cibus, Inc. (CBUS) has a market capitalization of $66.6M.

What is CBUS's P/E ratio?

A meaningful P/E ratio is not available for CBUS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CBUS's price-to-book (P/B) ratio?

CBUS trades at 3.05 times book value per share.

When did Cibus, Inc. last report earnings?

CBUS last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying CBUS stock?

SEC Form 4 filings show no open-market insider buys at Cibus, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

TCRX

TScan Therapeutics, Inc.

$67.2M

MNOV

MediciNova, Inc.

$66M

IMA

ImageneBio Inc

$65.9M

CLNN

Clene Inc.

$67.7M

SPRB

Spruce Biosciences, Inc.

$68.2M

IMMP

Immutep Limited

$65M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.